Grafton™ DBF Inject A premium injectable Bone Graft solution
From the Grafton™ family of DBM products that offers an injectable format with handling characteristics suited to minimally invasive procedures.
Request information
Overview
Grafton™ DBF Inject is a line extension of the Grafton™ family of DBM products that offers an injectable format. Grafton™ DBF Inject combines high osteoinductive DBM with a unique graft delivery syringe that can deliver graft material directly into the surgical site.
Key benefits
100% injectable
demineralized fibers
A proven osteoinductive DBM and delivery solution all in one
Available in multiple volumes to accommodate diverse surgical applications
Product resources
A history of clinical success
The technology in Grafton™ DBF Inject is backed by more than 30 years of clinical history over 50 peer-reviewed publications. Discover why surgeons worldwide trust Grafton™ for reliable, consistent performance in bone grafting applications.
Product features & Specifications
Unique syringe design
The graft delivery syringe cannula can easily access the interbody space, making Grafton™ DBF Inject well suited for filling both into and around approved cages placed during both Open and MIS TLIF, PLIF and OLIF procedures.
Fiber Flow Technology
Grafton™ DBF Inject and its patended* fiber technology enables the first flowable carrier-free Fiber DBM on the market today.
Improved workflow
By eliminating the need for a bone funnel and tamp, Grafton™ DBF Inject has the potential to reduce the number of steps needed to deliver bone graft and improve OR efficiences.
All-in-one Hydration
Our unique syringe design allows for seamless hydration and delivery of our premium, Grafton™ DBF bone graft.
100% Carrier-Free DBM Fiber
By eliminating the glycerol carrier, Grafton™ DBF Inject improves on the groundbreaking Grafton™ DBM technology by producing a more versatile osteoinductive bone graft.1
Integration with Catalyft™ Expandable Interbody System
Grafton™ DBF Inject seamlessly integrates with Catalyft™ with bone graft flowing through the inserter and expanded into implant to completely fill the disc space.
Available configurations
| Part Number |
Description |
Graft Volume |
|---|---|---|
| T50303INT |
Grafton™ DBF Inject |
3cc |
| T50306INT |
Grafton™ DBF Inject |
6cc |
| T50309INT |
Grafton™ DBF Inject |
9cc |
Clinical evidence
Proven clinical results
The Grafton™ family of products has a long history of clinical success, with numerous studies demonstrating its efficacy and safety profile.
Key clinical findings include:
- Demonstrated successful fusion rates in spinal applications
- Effective bone void filling capabilities
- Consistent osteoinductive potential across lots
- Long-term follow-up confirming sustained outcomes
Proven clinical results
Demineralized Bone Matrix Carries and their Clinical Applications: An Overview
Journal of Orthopaedic Surgery, 2017
Efficacy comparison of Accell Evo3 and Grafton™ demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model
The Spine Journal, 2017
Demineralized Bone Matrix in Spine Surgery: A Review of Current Applications and Future Trends
International Journal of Spine Surgery, 2021
Related products
*
Patent number: US 10,660,685 B2.
†
Animal testing is not necessarily indicative of human clinical outcomes.
1
Data on file. Memo RAT OI Chart 09-01-2022 version 1. Based on internal testing in an athymic rat model. Histology scoring based on Edwards JT, Diegmann MH, Scarborough NL. Osteoinduction of human demineralized bone: characterization in a rat model. Clin Orthop Relat Res. 1998;357:219-228.
2
Martin, G.J. et al. Spine. 1999;24(7):637-645.
The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s)(opens new window).
Please note that the intended use of a product may vary depending on geographical approvals.
See the device manual(s)(opens new window) for detailed information regarding the intended use, the (implant) procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For a MRI compatible device(s), consult the MRI information in the device manual(s)(opens new window) before performing a MRI.
If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com(opens new window).
Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable).
For any further information, contact your local Medtronic representative.